Topiramate for the Treatment of Methamphetamine Dependence - 1

Completed · Phase 2 · Has a placebo group

Conditions studied: Methamphetamine

In brief

The purpose of this study is to assess the efficacy and safety of topiramate as compared to placebo in reducing methamphetamine use in subjects with methamphetamine dependence.

Key facts

Study ID

NCT00345371

Run by

National Institute on Drug Abuse (NIDA)

People needed

140

Starts

2006-04-01

Expected to finish

2008-12-01

Last updated by the study team

2017-03-27

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Treatment seeking individuals as the time of the study
• Must be able to proved written informed consent
• Must have a body mass index greater than 18 kg/m(2)
• Must meet DSM-IV criteria for methamphetamine dependence
• Must currently be using methamphetamine as confirmed by a positive urine test over the past 14 days
• If female of child bearing potential, must agree to use birth control

You may not qualify if…

• Please contact the site for more information

Where it is running

• Matrix Institute on Addictions — Costa Mesa, California, United States
• South Bay Treatment Center — San Diego, California, United States
• Torrance Site — Torrance, California, United States
• John A. Burns School of Medicine — Honolulu, Hawaii, United States
• Powell Chemical Dependency Center — Des Moines, Iowa, United States
• University of Missouri - Kansas City — Kansas City, Missouri, United States
• Salt Lake City VA Medical Center — Salt Lake City, Utah, United States
• UVA CARE — Charlottesville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.